Richard Eisenstadt
2018 - Neos Therapeutics
In 2018, Richard Eisenstadt earned a total compensation of $833.4K as Chief Financial Officer at Neos Therapeutics, a 18% increase compared to previous year.
Compensation breakdown
| Bonus | $55,122 |
|---|---|
| Option Awards | $272,324 |
| Salary | $335,733 |
| Stock Awards | $155,625 |
| Other | $14,564 |
| Total | $833,368 |
Eisenstadt received $335.7K in salary, accounting for 40% of the total pay in 2018.
Eisenstadt also received $55.1K in bonus, $272.3K in option awards, $155.6K in stock awards and $14.6K in other compensation.
Rankings
In 2018, Richard Eisenstadt's compensation ranked 10,015th out of 14,244 executives tracked by ExecPay. In other words, Eisenstadt earned more than 29.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,015 out of 14,244 | 30th |
Division Manufacturing | 4,043 out of 5,765 | 30th |
Major group Chemicals And Allied Products | 1,522 out of 2,128 | 29th |
Industry group Drugs | 1,285 out of 1,817 | 29th |
Industry Pharmaceutical Preparations | 986 out of 1,391 | 29th |
Source: SEC filing on April 24, 2019.
Eisenstadt's colleagues
We found three more compensation records of executives who worked with Richard Eisenstadt at Neos Therapeutics in 2018.
News
PharmAthene CEO Vipin Garg's 2022 pay rises 9% to $2.9M
August 16, 2023
PharmAthene CEO Vipin Garg's 2021 pay jumps 83% to $2.6M
August 16, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
Neos Therapeutics CEO Gerald McLaughlin's 2019 pay falls 56% to $1.4M
April 21, 2020
Neos Therapeutics CEO Gerald McLaughlin receives $3.2M in 2018
April 24, 2019